Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma

Transplantation Proceedings

Volumn 43, Issue 10, 2011, Pages 3807-3812

  Aktas, S ^a   Karakayali, H ^a   Moray, G ^a   Ozdemir, H ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIBODY; KI 67 ANTIGEN; RAPAMYCIN; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER NODULE; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SURGICAL RISK; SURVIVAL TIME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; KI-67 ANTIGEN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TURKEY; YOUNG ADULT;

EID: 83655203595     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.09.067     Document Type: Conference Paper

References (25)

1. D.M. Parkin, F. Bray, J. Ferlay et al. Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
2. W.Y. Lau, E.C. Lai Hepatocellular carcinoma: current management and recent advances Hepatobil Pancreat Dis Int 7 2008 237
3. M.B. Thomas, A.X. Zhu Hepatocellular carcinoma: the need for progress J Clin Oncol 23 2005 2892
4. F.Y. Yao, L. Ferrell, N.M. Bass et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394
5. H. Karakayali, S. Pehlivan, M.C. Yagmurdur et al. Effect of graft type on postoperative liver function recovery in living liver donors Transplant Proc 41 2009 2855
6. H. Karakayali, F. Boyvat, M. Coskun et al. Venous complications after orthotopic liver transplant Transplant Proc 38 2006 604
7. S. Sevmis, H. Karakayali, N.U. Tutar et al. Management of early hepatic arterial thrombosis after pediatric living-donor liver transplantation Transplant Proc 43 2011 605
8. H.A. Edmondson, P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462
9. A. Bharat, D.B. Brown, J.S. Crippin et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival J Am Coll Surg 203 2006 411
10. B.H. Ozdemir, A. Sezgin, M. Haberal Apoptosis and proliferation of cardiomyocytes and interstitial mononuclear cells: association with rejection and macrophage infiltration Transplant Proc 41 2009 2890
11. R. Williams, M. Smith, K.B. Shilkin et al. Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases Gastroenterology 64 1973 1026
12. E. Regalia, J. Coppa, A. Pulvirenti et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience Transplant Proc 33 2001 1442
13. V. Mazzaferro, C. Battiston, S. Perrone et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study Ann Surg 240 2004 900
14. V. Mazzaferro, E. Regalia, R. Doci et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
15. H.H. Lee, J.W. Joh, J.H. Park et al. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma Transplant Proc 37 2005 1251
16. S. Jonas, W.O. Bechstein, T. Steinmller et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080
17. A. Plessier, L. Codes, Y. Consigny et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma Liver Transpl 10 2004 S86
18. E. Unitt, A. Marshall, W. Gelson et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation J Hepatol 45 2006 246
19. M. Ravaioli, G. Ercolani, M. Cescon et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria Liver Transpl 10 2004 1195
20. M. Peck-Radosavljevic, J. Pidlich, M. Bergmann et al. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood Liver Transplant Oncology Group J Hepatol 28 1998 497
21. A. Tannapfel, F. Geissler, F. Köckerling et al. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma J Pathol 187 1999 439
22. G. Guzman, V. Alagiozian-Angelova, J.E. Layden-Almer et al. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients Mod Pathol 18 2005 1498
23. V. Mazzaferro, Y.S. Chun, R.T. Poon et al. Liver transplantation for hepatocellular carcinoma Ann Surg Oncol 15 2008 1001
24. J. Li, L.N. Yan, J. Yang et al. Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients World J Gastroenterol 15 2009 4170
25. J.M. Regimbeau, E.K. Abdalla, J.N. Vauthey et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study J Surg Oncol 85 2004 36